Gilead Sciences Inc (NASDAQ:GILD)

62.27
BATS BZX Real-Time Price
As of 9:43am ET
 +0.87 / +1.42%
Today’s Change
56.56
Today|||52-Week Range
85.97
+6.88%
Year-to-Date
Intercept's (ICPT) Q4 Loss Wider than Expected, Sales Miss
Feb 26 / Zacks.com - Paid Partner Content
Is Galapagos Stock a Bad-News Buy Right Now?
Feb 23 / MotleyFool.com - Paid Partner Content
FATE Reports Wider-Than-Expected Q4 Loss on Higher Expenses
Feb 25 / Zacks.com - Paid Partner Content
Your 2 Best Profit Opportunities in 2021
Feb 20 / MotleyFool.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Apple, Procter & Gamble, Deere, T-Mobile US and Gilead Sciences
Feb 24 / Zacks.com - Paid Partner Content
Vir Biotechnology and GlaxoSmithKline Expand Their Partnership
Feb 17 / MotleyFool.com - Paid Partner Content
3 Top-Rated Value Stocks to Buy in March
Feb 24 / StockNews.com - Paid Partner Content
Here's What Caused Royalty Pharma's Mixed Results in Q4
Feb 17 / MotleyFool.com - Paid Partner Content
Top Analyst Reports for Apple, P&G, Deere & Others
Feb 23 / Zacks.com - Paid Partner Content
Stock Market News for Feb 17, 2021
Feb 17 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close61.40
Today’s open61.74
Day’s range61.65 - 62.27
Volume36,654
Average volume (3 months)9,358,418
Market cap$77.2B
Data as of 9:43am ET, 03/01/2021

Growth & Valuation

Earnings growth (last year)-97.69%
Earnings growth (this year)-0.14%
Earnings growth (next 5 years)+2.00%
Revenue growth (last year)+10.39%
P/E ratio63.5
Price/Sales2.99
Price/Book4.23

Competitors

 Today’s
change
Today’s
% change
ILMNIllumina Inc+8.13+1.85%
MRNAModerna Inc-4.01-2.59%
BIIBBiogen+1.64+0.60%
AMGNAmgen+2.28+1.01%
Data as of 9:43am ET, 03/01/2021

Financials

Next reporting dateMay 4, 2021
EPS forecast (this quarter)$2.02
Annual revenue (last year)$24.6B
Annual profit (last year)$123.0M
Net profit margin0.50%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Foster City, California

Forecasts